Bladder cancer hunting: a microfluidic paper-based analytical device

Bladder Cancer
12/06/2020

Jiang Q, et al. Electrophoresis 2020.

ABSTRACT

Bladder cancer is the 4th most common cancer in men, and it is becoming a prevalent malignancy. Most of the regular clinical examinations are prompt evaluations with cystoscopy, renal function testing, which require high-precision instrument, well-trained operators and high cost. In this study, a microfluidic paper-based analytical device (μPAD) was fabricated to detect nuclear matrix protein 22 (NMP22) and bladder cancer antigen (BTA) from the urine samples. Urine samples were collected from 11 bladder cancer patients and 10 well-beings as experiment and control groups respectively, to verify the working efficiency of μPAD. A remarkable checkout efficiency of up to 90.91% was found from the results. Meanwhile, this method is feasible for home-based self-detection from urine samples within 10 minutes for the total process, which provides a new way for quick, economical and convenient tumor diagnosis, prognosis evaluation and drug response. This article is protected by copyright. All rights reserved.